AMG 193 Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol)
Summary
- Eligibility
- for people ages 18-100 (full criteria)
- Location
- at Los Angeles, California and other locations
- Dates
- study startedcompletion around
- Principal Investigator
- by Jonathan Goldman, MD

Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCLA
- Jonathan Goldman, MD
Hs Clinical Professor, Medicine. Authored (or co-authored) 112 research publications
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Amgen
- Links
- AmgenTrials clinical trials website Sign up for this study
- ID
- NCT06333951
- Phase
- Phase 1 research study
- Study Type
- Interventional
- Participants
- Expecting 500 study participants
- Last Updated